Literature DB >> 10492638

The rise in incidence of lymphomas in Europe 1985-1992.

R Cartwright1, H Brincker, P M Carli, D Clayden, J W Coebergh, A Jack, R McNally, G Morgan, S de Sanjose, R Tumino, M Vornanen.   

Abstract

A collaborative study was carried out of the descriptive epidemiology of the lymphomas from seven countries across Europe in the period 1985-1992. Careful attention was paid to sources of information and the data quality in close collaboration with expert histopathologists. The data were classified as non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD). An attempt was made to put the data into a modified version of the Revised European American Lymphoma (REAL) classification. We observed an overall rise in total NHL throughout the time period in all European countries but no such trend in HD. The increase in NHL overall being 4.2% per annum, representing an increase of 4.8% in males and 3.4% in females per annum, was only marked in middle and old age. Such increases were observed in all participating areas except in Burgundy. Different countries, however, have different base rates, the rates being highest in Scandinavia and the Netherlands. The analysis by subcategory classification suggested that the increase in NHL was confined to the follicle centre cell type, extranodal B-cell, nodal T-cell and nodal lymphomas not otherwise specified, categories. These new observations present a picture of real increase in case incidence with no obvious explanation. The increases in NHL do not appear to be due solely to better diagnoses. Pending other explanations or refutation, these present a compelling picture of an inexorable rise in incidence of this disease.

Entities:  

Mesh:

Year:  1999        PMID: 10492638     DOI: 10.1016/s0959-8049(98)00401-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  28 in total

1.  Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.

Authors:  Lindsay M Morton; Sophia S Wang; Susan S Devesa; Patricia Hartge; Dennis D Weisenburger; Martha S Linet
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

Review 2.  PET in lymphoma.

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2006-10-31       Impact factor: 3.909

3.  Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000.

Authors:  T Mitterlechner; M Fiegl; H Mühlböck; W Oberaigner; S Dirnhofer; A Tzankov
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

Review 4.  Epidemiology and pathologic features of Hodgkin lymphoma.

Authors:  Shin-ichi Nakatsuka; Katsuyuki Aozasa
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

5.  A collaborative nationwide lymphoma study in Lebanon: incidence of various subtypes and analysis of associations with viruses.

Authors:  Zaher K Otrock; Jad Saab; Georges Aftimos; Fady Nasr; Fadi S Farhat; Saad Khairallah; Gérard Abadjian; Marwan Ghosn; Hassan Sidani; Ahmad Ibrahim; Ayman Tawil; Claude Ghorra; Zarouhie Meguerian; Walid Mokaddem; Walid Dayeh; Ziad Salem; Georges Chahine; Nizar Bitar; Anas Mugharbel; Joseph Makdessi; Christina Khater; Mirna El Hajj; Dany Abi Gerges; Charles Sfeir; Joseph Kattan; Khaled Ibrahim; Michel Saade; Hussein Sadek; Rami A Mahfouz; Mohamed A Kharfan-Dabaja; Ghazi Zaatari; Ali Bazarbachi
Journal:  Pathol Oncol Res       Date:  2013-05-08       Impact factor: 3.201

6.  Perinatal and family risk factors for non-Hodgkin lymphoma in early life: a Swedish national cohort study.

Authors:  Casey Crump; Kristina Sundquist; Weiva Sieh; Marilyn A Winkleby; Jan Sundquist
Journal:  J Natl Cancer Inst       Date:  2012-05-22       Impact factor: 13.506

Review 7.  Hodgkin's lymphoma presents as an inguinal abscess: a case report and literature review.

Authors:  Muwaffaq Mezeil Telfah
Journal:  BMJ Case Rep       Date:  2012-09-21

8.  Medical history and risk of lymphoma: results of a European case-control study (EPILYMPH).

Authors:  Nikolaus Becker; Joan Fortuny; Tomas Alvaro; Alexandra Nieters; Marc Maynadié; Lenka Foretova; Anthony Staines; Paul Brennan; Paolo Boffetta; Pier Luigi Cocco; Silvia de Sanjose
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-11       Impact factor: 4.553

Review 9.  Role of consolidation with yttrium-90 ibritumomab tiuxetan in patients with advanced-stage follicular lymphoma.

Authors:  Antonio C Sánchez Ruiz; Luis de la Cruz-Merino; Mariano Provencio Pulla
Journal:  Ther Adv Hematol       Date:  2014-06

Review 10.  PET/CT in oncology: for which tumours is it the reference standard?

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.